A new era of early cancer detection with blood test may change cancer screening ...
Dr Deb Schrag, Memorial Sloan Kettering Cancer Center, New York, USA
A new era of early cancer detection with blood test may change cancer screening paradigms ( Dr Deb Schrag, Memorial Sloan Kettering Cancer Center, New York, USA )
11 Sep 2022
New era of early cancer detection blood tests on the horizon
Dr Deborah Schrag - Memorial Sloan Kettering Cancer Center, New York City, USA
New era of early cancer detection blood tests on the horizon ( Dr Deborah Schrag - Memorial Sloan Kettering Cancer Center, New York City, USA )
11 Sep 2022
Prognostic model of all-cause mortality at 30 days in patients with cancer and C...
Dr Chris Labaki - Dana-Farber Cancer Institute, Boston, USA
Prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19 ( Dr Chris Labaki - Dana-Farber Cancer Institute, Boston, USA )
11 Sep 2022
New data presented at ESMO for multi-cancer early detection
Dr Tom Beer - Vice President and Chief Medical Officer of Exact Sciences
New data presented at ESMO for multi-cancer early detection ( Dr Tom Beer - Vice President and Chief Medical Officer of Exact Sciences )
10 Sep 2022
Bladder cancer: Current state and future directions in treatment
Prof Jorge Garcia - GU Medical Oncology Program, UH Seidman Cancer Center, Case ...
Bladder cancer: Current state and future directions in treatment ( Prof Jorge Garcia - GU Medical Oncology Program, UH Seidman Cancer Center, Case Western Reserve University, Cleveland, USA )
15 Aug 2022
Optimum treatment algorithm in management of advanced prostate cancer
Prof Jorge Garcia - GU Medical Oncology Program, UH Seidman Cancer Center, Case ...
Optimum treatment algorithm in management of advanced prostate cancer ( Prof Jorge Garcia - GU Medical Oncology Program, UH Seidman Cancer Center, Case Western Reserve University, Cleveland, USA )
15 Aug 2022
Working to improve global cancer care access in low middle-income countries
Dr Julie Gralow, Prof Eduardo Cazap
Working to improve global cancer care access in low middle-income countries ( Dr Julie Gralow, Prof Eduardo Cazap )
25 Jul 2022
Prostate cancer screening: A novel risk prediction tool with standard biopsies v...
Dr Lars Björnebo - The Karolinska Institute, Solna, Sweden
Prostate cancer screening: A novel risk prediction tool with standard biopsies vs PSA with MRI-targeted biopsies ( Dr Lars Björnebo - The Karolinska Institute, Solna, Sweden )
20 Jul 2022
Updates from the PROpel and MAGNITUDE studies
Prof Phil Cornford and Dr Elena Castro
Updates from the PROpel and MAGNITUDE studies ( Prof Phil Cornford and Dr Elena Castro )
11 Jul 2022
Current EAU guidelines on treating prostate cancer
Prof Eleni Efstathiou and Prof Nicolas Mottet
Current EAU guidelines on treating prostate cancer ( Prof Eleni Efstathiou and Prof Nicolas Mottet )
11 Jul 2022
Update on the latest in PARP inhibitors for prostate cancer
Prof Axel Merseburger and Prof Bertrand Tombal
Update on the latest in PARP inhibitors for prostate cancer ( Prof Axel Merseburger and Prof Bertrand Tombal )
11 Jul 2022
Prostate roundup what have we learned from EAU and ASCO 2022?
Prof Eleni Efstathiou and Prof Nicolas Mottet
Prostate roundup what have we learned from EAU and ASCO 2022? ( Prof Eleni Efstathiou and Prof Nicolas Mottet )
11 Jul 2022